Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.Read More
Filter By Category
In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.Read More
The World Health Organization-approved eLearning tool can be used regardless of Internet access.Read More
Access Bio and Global Good collaborate for five-fold improvement in pLDH marker detection for HRP2-deleted P. falciparum
New, high-impact detection kit will prove useful for both P. falciparum and P. vivax species.Read More
“With this license, we are one step closer to ending the unlicensed use of our technology by the insurance industry,” said Mathen Ganesan, executive vice president, Invention Investment Fund at Intellectual Ventures.Read More
Algorithm could revolutionize cervical cancer screening, especially in low-resource settings.Read More
Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.Read More
New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.Read More
Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.Read More
Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.Read More
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.Read More
EarthNow announced exciting new updates in its mission to establish high-res, real time video from space. The IV spinout hopes to launch its first satellite by 2020.Read More
Harvard Business Review
IV co-founder Edward Jung was in Harvard Business Review for contributing a piece on Local Innovation Bonds and different ways to invest in tech startups.Read More
Puget Sound Business Journal
Tony Pan, co-founder and CEO of IV spinout Modern Electron, was named Puget Sound Business Journal’s Innovator of the Month this December.Read More
The Seattle Times
IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.Read More